Jazz Pharmaceuticals JAZZ Return on invested capital

Return on invested capital at other companies

AmgenAMGN

14.8%+3.6pp

AlkermesALKS

3.9%-23.7pp

Xenon PharmaceuticalsXENE

-54%+2.2pp

Stoke Therapeutics, Inc.STOK

-114.4%—

Praxis Precision Medicines, Inc.PRAX

-67.9%-17.5pp

Amneal Pharmaceuticals, Inc.AMRX

20.3%+10.3pp

FAQ

What is Jazz Pharmaceuticals's return on invested capital?

Jazz Pharmaceuticals (JAZZ) reported return on invested capital of -6.1% in Q3 2025.

How has Jazz Pharmaceuticals's return on invested capital changed year-over-year?

Jazz Pharmaceuticals's return on invested capital decreased by 175.6% year-over-year, from 8.1% to -6.1%.

What is the long-term trend for Jazz Pharmaceuticals's return on invested capital?

Over 4 years (2020 to 2024), Jazz Pharmaceuticals's return on invested capital has grown at a 5.5% compound annual growth rate (CAGR), from 7.3% to 9%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.